CLINICAL_TRIALS
trial_result
· 2013-02-01
Clinical Trial Update: PF-04191834 Single Dose Bronchodilatory Study In Asthma. [Phase 2]
Summary
A Phase 2 single-dose bronchodilatory study of PF-04191834 in asthma has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-02-01